The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Lipodystrophy: pathophysiology and advances in treatment
Open accessAbstract
Lipodystrophy is a medical condition characterized by complete or partial loss of adipose tissue. Not infrequently, lipodystrophy occurs in combination with pathological accumulation of adipose tissue at distinct anatomical sites. Patients with lipodystrophy exhibit numerous metabolic complications, which indicate the importance of adipose tissue as an active endocrine organ. Not only the total amount but also the appropriate distribution of adipose tissue depots contribute to the metabolic state. Genetic and molecular research has improved our understanding of the mechanisms underlying lipodystrophy. Circulating levels of hormones secreted by the adipose tissue, such as leptin and adiponectin, are greatly reduced in distinct subpopulations of patients with lipodystrophy. This finding rationalizes the use of these adipokines or of agents that increase their circulating levels, such as peroxisome proliferator-activated receptor γ (PPARγ) agonists, for therapeutic purposes. Other novel therapeutic approaches, including the use of growth hormone and growth-hormone-releasing factors, are also being studied as potential additions to the therapeutic armamentarium. New insights gained from research and clinical trials could potentially revolutionize the management of this difficult-to-treat condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdán, M. G., Diano, S., Horvath, T. L., Cone, R. D., & Low, M. J. (2001) · Nature · doi:10.1038/35078085 · Cited by 2,356
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S., & Carr, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,070
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800
Life without white fat: a transgenic mouse
Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.20.3168 · Cited by 782
Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13
Magré, J., Delépine, M., Khallouf, E., Gedde-Dahl, T., Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 756
Lago, R. M., Singh, P. P., & Nesto, R. W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61514-1 · Cited by 710
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J. K., Shulman, G. I., Castle, A. L., Vinson, C., Eckhaus, M., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7901 · Cited by 676
Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
Kelesidis, T., Kelesidis, I., Chou, S., & Mantzoros, C. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00008 · Cited by 666
Self-citationCao, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.109 · Cited by 662
Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110970200 · Cited by 583
Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D., Glesby, M. J., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 580
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559
Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C
Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D’Apice, M. R., Massart, C., Capon, F., Sbraccia, P., Federici, M., Lauro, R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341908 · Cited by 553
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
Agarwal, A. K., Arioglu, E., de Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I., & Garg, A. (2002) · Nature Genetics · doi:10.1038/ng880 · Cited by 523
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8456 · Cited by 443
Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia
Agarwal, A. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg213 · Cited by 401
Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies
Haque, W. A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2395 · Cited by 395
Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S., Park, Y.-E., Nonaka, I., Hino-Fukuyo, N., Haginoya, K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38660 · Cited by 394
Kim, C. A., Delépine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1328 · Cited by 391
Metformin in the Treatment of HIV Lipodystrophy Syndrome: A Randomized Controlled Trial
Hadigan, C., Corcoran, C., Basgoz, N., Davis, B., Sax, P., & Grinspoon, S. (2000) · JAMA · doi:10.1001/jama.284.4.472 · Cited by 357
Fichtenbaum, C. J., Gerber, J. G., Rosenkranz, S. L., Segal, Y., Aberg, J. A., Blaschke, T., Alston, B., Fang, F., Kosel, B., & Aweeka, F. (2002) · AIDS · doi:10.1097/00002030-200203080-00008 · Cited by 338
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Metabolic Effects of a Growth Hormone–Releasing Factor in Patients with HIV
Falutz, J., Allas, S., Blot, K., Potvin, D., Kotler, D., Somero, M., Berger, D., Brown, S., Richmond, G., Fessel, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072375 · Cited by 312
Rubio‐Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S., Hyden, C. S. S., Bottomley, W., Vigouroux, C., Magré, J., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900037 · Cited by 298
Misra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
Agarwal, A. K., & Garg, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8290 · Cited by 268
Haubrich, R. H., Riddler, S. A., DiRienzo, A. G., Komarow, L., Powderly, W. G., Klingman, K., Garren, K. W., Butcher, D. L., Rooney, J. F., Haas, D. W., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832b4377 · Cited by 254
Misra, A., & Garg, A. (2003) · Medicine · doi:10.1097/00005792-200303000-00007 · Cited by 241
Ebihara, K., Ogawa, Y., Masuzaki, H., Shintani, M., Miyanaga, F., Aizawa-Abe, M., Hayashi, T., Hosoda, K., Inoue, G., Yoshimasa, Y., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1440 · Cited by 240
Carr, A., Workman, C., Carey, D., Rogers, G., Martin, A., Baker, D., Wand, H., Law, M., Samaras, K., Emery, S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15489-5 · Cited by 240
Ebihara, K., Kusakabe, T., Hirata, M., Masuzaki, H., Miyanaga, F., Kobayashi, N., Tanaka, T., Chusho, H., Miyazawa, T., Hayashi, T., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1546 · Cited by 232
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†
Javor, E. D., Ghany, M. G., Cochran, E. K., Oral, E. A., DePaoli, A. M., Premkumar, A., Kleiner, D. E., & Gorden, P. (2005) · Hepatology · doi:10.1002/hep.20672 · Cited by 228
Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy
Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., DePaoli, A. M., & Gorden, P. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1994 · Cited by 226
Cortés, V. A., Curtis, D. E., Sukumaran, S., Shao, X., Parameswara, V., Rashid, S., Smith, A. R., Ren, J., Esser, V., Hammer, R. E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.002 · Cited by 226
Addy, C. L., Gavrila, A., Tsiodras, S., Brodovicz, K., Karchmer, A. W., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020795 · Cited by 220
Self-citationKoutkia, P., Canavan, B., Breu, J., Torriani, M., Kissko, J., & Grinspoon, S. (2004) · JAMA · doi:10.1001/jama.292.2.210 · Cited by 215
Vigouroux, C., Maachi, M., Nguyên, T.-H., Coussieu, C., Gharakhanian, S., Funahashi, T., Matsuzawa, Y., Shimomura, I., Rozenbaum, W., Capeau, J., et al. (2003) · AIDS · doi:10.1097/00002030-200307040-00011 · Cited by 211
Lundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., et al. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00534.x · Cited by 210
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy
Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyn, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419511 · Cited by 210
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy
Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyn, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19511 · Cited by 210
Metabolic Effects of Rosiglitazone in HIV Lipodystrophy: A Randomized, Controlled Trial
Hadigan, C., Yawetz, S., Thomas, A., Havers, F., Sax, P. E., & Grinspoon, S. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00008 · Cited by 208
Hegele, R. A., Cao, H., Liu, D. M., Costain, G. A., Charlton-Menys, V., Rodger, N. W., & Durrington, P. N. (2006) · The American Journal of Human Genetics · doi:10.1086/505885 · Cited by 207
Lo, J. (2008) · JAMA · doi:10.1001/jama.300.5.509 · Cited by 200
The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
Payne, V. A., Grimsey, N., Tuthill, A., Virtue, S., Gray, S. L., Dalla Nora, E., Semple, R. K., O'Rahilly, S., & Rochford, J. J. (2008) · Diabetes · doi:10.2337/db08-0184 · Cited by 199
Garg, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.1776 · Cited by 189
Sutinen, J., Häkkinen, A.-M., Westerbacka, J., Seppälä-Lindroos, A., Vehkavaara, S., Halavaara, J., Järvinen, A., Ristola, M., & Yki-Järvinen, H. (2003) · Antiviral Therapy · doi:10.1177/135965350300800303 · Cited by 189
Lagathu, C., Eustace, B., Prot, M., Frantz, D., Gu, Y., Bastard, J.-P., Maachi, M., Azoulay, S., Briggs, M., Caron, M., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200407 · Cited by 185
Lipodystrophies: disorders of adipose tissue biology.
Garg, A., & Agarwal, A. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.014 · Cited by 184
Simha, V., & Garg, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030835 · Cited by 180
Ceddia, R. B. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803025 · Cited by 178
Role of Leptin in Reproduction
MANTZOROS, C. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06228.x · Cited by 177
Self-citationEfficacy of leptin therapy in the different forms of human lipodystrophy
Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Gorden, P. (2010) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 177
Duan, S. Z., Ivashchenko, C. Y., Whitesall, S. E., D’Alecy, L. G., Duquaine, D. C., Brosius, F. C., Gonzalez, F. J., Vinson, C., Pierre, M. A., Milstone, D. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28859 · Cited by 172
Lindegaard, B., Hansen, T. F., Hvid, T., van Hall, G., Plomgaard, P., Ditlevsen, S., Gerstoft, J., & Pedersen, B. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2733 · Cited by 171
Gerber, J. G., Rosenkranz, S. L., Fichtenbaum, C. J., Vega, J. M., Yang, A., Alston, B. L., Brobst, S. W., Segal, Y., & Aberg, J. A. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000167156.44980.33 · Cited by 167
Franz, M. J., Bantle, J. M., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Ann Holzmeister, L., Hoogwerf, B., Mayer-Davis, E., Mooradian, A., et al. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90031-3 · Cited by 166
AdipoR1 mediates the anorexigenic and insulin/leptin‐like actions of adiponectin in the hypothalamus
Coope, A., Milanski, M., Araújo, E. P., Tambascia, M., Saad, M. J. A., Geloneze, B., & Velloso, L. A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.037 · Cited by 165
Lee, J. H., Chan, J. L., Sourlas, E., Raptopoulos, V., & Mantzoros, C. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1545 · Cited by 163
Self-citationInhibition of Mitochondrial Function by Efavirenz Increases Lipid Content in Hepatic Cells
Blas-García, A., Apostolova, N., Ballesteros, D., Monleón, D., Morales, J. M., Rocha, M., Victor, V. M., & Esplugues, J. V. (2010) · Hepatology · doi:10.1002/hep.23647 · Cited by 159
Hadigan, C., Borgonha, S., Rabe, J., Young, V., & Grinspoon, S. (2002) · Metabolism · doi:10.1053/meta.2002.34704 · Cited by 158
Measuring body fat distribution and content in humans
Goodpaster, B. H. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200209000-00005 · Cited by 157
Thiazolidinedione Treatment Decreases Bone Mineral Density in Type 2 Diabetic Men
Yaturu, S., Bryant, B., & Jain, S. K. (2007) · Diabetes Care · doi:10.2337/dc06-2606 · Cited by 155
Cao, H., Alston, L. R., Ruschman, J., & Hegele, R. A. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-3 · Cited by 149
Leow, M. K., Addy, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021704 · Cited by 148
Self-citationColombo, C., Cutson, J. J., Yamauchi, T., Vinson, C., Kadowaki, T., Gavrilova, O., & Reitman, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2727 · Cited by 147
Lipodystrophies: rare disorders causing metabolic syndrome
Garg, A., & Misra, A. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.003 · Cited by 147
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
Donati, K. D. G., Ricardo Rabagliati, B., Iacoviello, L., & Cauda, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00971-5 · Cited by 147
Musso, C., Cochran, E., Javor, E., Young, J., DePaoli, A. M., & Gorden, P. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.021 · Cited by 146
Boguslavsky, R. L., Stewart, C. L., & Worman, H. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi480 · Cited by 146
17th conference on retroviruses and opportunistic infections
松下, 修. (2010) · HIV感染症とAIDSの治療 · Cited by 144
Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy
Johnson, J. A., Albu, J., Engelson, E. S., Fried, S. K., Inada, Y., Ionescu, G. O., & Kotler, D. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00056.2003 · Cited by 141
Boutet, E., Mourabit, H. E., Prot, M., Nemani, M., Khallouf, E., Colard, O., Maurice, M., Durand‐Schneider, A., Chrétien, Y., Grès, S., et al. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.011 · Cited by 139
Yarasheski, K. E., Tebas, P., Stanerson, B. S., Claxton, S., Marin, D., Bae, K. T., Kennedy, M., Tantisiriwat, W., & Powderly, W. G. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.1.133 · Cited by 135
Exercise Training in HIV-1-Infected Individuals with Dyslipidemia and Lipodystrophy
TERRY, L., Sprinz, E., Stein, R., MEDEIROS, N. B., OLIVEIRA, J., & Ribeiro, J. P. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000191347.73848.80 · Cited by 133
Driscoll, S. D., Meininger, G. E., Lareau, M. T., Dolan, S. E., Killilea, K. M., Hadigan, C. M., Lloyd‐Jones, D. M., Klibanski, A., Frontera, W. R., & Grinspoon, S. K. (2004) · AIDS · doi:10.1097/00002030-200402200-00013 · Cited by 131
McDuffie, J. R., Riggs, P. A., Calis, K. A., Freedman, R. J., Oral, E. A., DePaoli, A. M., & Yanovski, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031868 · Cited by 129 · cited 1×
“an effect which is partially owing to increased satiety”
BackgroundMulligan, K., Khatami, H., Schwarz, J.-M., Sakkas, G. K., DePaoli, A. M., Tai, V. W., Wen, M. J., Lee, G. A., Grunfeld, C., & Schambelan, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1588 · Cited by 127
WANKE, C. A., Gerrior, J., Kantaros, J., Coakley, E. P. G., & Albrecht, M. (1999) · AIDS · doi:10.1097/00002030-199910220-00013 · Cited by 125
Tong, Q., Sankalé, J.-L., Hadigan, C. M., Tan, G., Rosenberg, E. S., Kanki, P. J., Grinspoon, S. K., & Hotamışlıgil, G. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021600 · Cited by 123
Xu, A., Yin, S., Wong, L. S. L., Chan, K. W., & Lam, K. S. L. (2003) · Endocrinology · doi:10.1210/en.2003-1140 · Cited by 120
Köbberling Type of Familial Partial Lipodystrophy
Herbst, K. L., Tannock, L. R., Deeb, S. S., Purnell, J. Q., Brunzell, J. D., & Chait, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1819 · Cited by 119
Rydén, M., & Arner, P. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01854.x · Cited by 118
Jones, S. P., Doran, D. A., Leatt, P., Maher, B., & Pirmohamed, M. (2001) · AIDS · doi:10.1097/00002030-200110190-00021 · Cited by 117
Gelato, M. C., Mynarcik, D. C., Quick, J. L., Steigbigel, R. T., Fuhrer, J., BRATHWAITE, C. E. M., Brebbia, J. S., Wax, M. R., & McNurlan, M. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200210010-00006 · Cited by 115
Javor, E. D., Moran, S. A., Young, J. R., Cochran, E. K., DePaoli, A. M., Oral, E. A., Turman, M. A., Blackett, P. R., Savage, D. B., O’Rahilly, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032140 · Cited by 114
Nagy, G. S., Tsiodras, S., Martin, L. D., Avihingsanon, A., Gavrila, A., Hsu, W. C., Karchmer, A. W., & Mantzoros, C. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367859 · Cited by 114
Self-citationMynarcik, D. C., Combs, T. P., McNurlan, M. A., Scherer, P. E., Komaroff, E., & Gelato, M. C. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212150-00009 · Cited by 113
HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options
Mallewa, J. E., Wilkins, E., Vilar, J., Mallewa, M., Doran, D. A., Back, D. J., & Pirmohamed, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn251 · Cited by 109
Villarroya, F., Domingo, P., & Giralt, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.018 · Cited by 108
Hadri, K. E., Glorian, M., Monsempès, C., Dieudonné, M., Pecquery, R., Giudicelli, Y., Andréani, M., Dugail, I., & Fève, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312875200 · Cited by 104
Park, J. Y., Javor, E. D., Cochran, E. K., DePaoli, A. M., & Görden, P. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.010 · Cited by 104
Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report
Wu, J., Song, Y., Li, H., & Chen, J. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0723-7 · Cited by 103
Engelson, E. S., Glesby, M. J., Mendez, D., Albu, J., Wang, J., Heymsfield, S. B., & Kotler, D. P. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200208010-00002 · Cited by 99
Fertility and Obstetrical Complications in Women withLMNA-Related Familial Partial Lipodystrophy
Vantyghem, M., Vincent-Desplanques, D., Defrance-Faivre, F., Capeau, J., Fermon, C., Valat, A. S., Lascols, O., Hécart, A. C., Pigny, P., Delemer, B., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2521 · Cited by 98
Blümer, R. M. E., van Vonderen, M. G. A., Sutinen, J., Hassink, E. A. M., Ackermans, M. T., van Agtmael, M. A., Yki‐Järvinen, H., Danner, S. A., Reiss, P., & Sauerwein, H. P. (2008) · AIDS · doi:10.1097/qad.0b013e3282f33557 · Cited by 97
Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy
Moran, S. A., Patten, N., Young, J. R., Cochran, E., Sebring, N., Reynolds, J., Premkumar, A., Depaoli, A. M., Skarulis, M. C., Oral, E. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.019 · Cited by 96
Stein, J. H., Merwood, M. A., Bellehumeur, J. L., Aeschlimann, S. E., Korcarz, C. E., Underbakke, G. L., Mays, M. E., & Sosman, J. M. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.018 · Cited by 96
Miller, J., Brown, D., Amin, J., Kent-Hughes, J., Law, M. G., Kaldor, J. M., Cooper, D. A., & Carr, A. D. (2002) · AIDS · doi:10.1097/00002030-200211080-00012 · Cited by 96
Mallon, P. W. G., Miller, J., Kovacic, J. C., Kent-Hughes, J., Norris, R., Samaras, K., Feneley, M. P., Cooper, D. A., & Carr, A. D. (2006) · AIDS · doi:10.1097/01.aids.0000222072.37749.5a · Cited by 91
Shrivastav, S., Kino, T., Cunningham, T., Ichijo, T., Schubert, U., Heinklein, P., Chrousos, G. P., & Kopp, J. B. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0124 · Cited by 91
Beltrand, J., Beregszàszi, M., Chevenne, D., Sebag, G. H., de Kerdanet, M., Huet, F., Polak, M., Tubiana‐Rufi, N., Lacombe, D., Paoli, A. M. D., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2006-3165 · Cited by 89
Hadigan, C. M., Rabe, J., & Grinspoon, S. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020709 · Cited by 88
Dunn, F. L., Higgins, L. S., Fredrickson, J. O., & DePaoli, A. M. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.006 · Cited by 87
Slama, L., Lanoy, É., Valantin, M., Bastard, J., Chermak, A., Boutekatjirt, A., Faltaos, D. W., Billaud, E., Molina, J., Capeau, J., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300107 · Cited by 86
Chandra, S., Mondal, D., & Agrawal, K. C. (2009) · Experimental Biology and Medicine · doi:10.3181/0811-rm-317 · Cited by 84
Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy
Oral, E. A., & Chan, J. L. (2010) · Endocrine Practice · doi:10.4158/ep09155.ra · Cited by 82
Falutz, J., Potvin, D., Mamputu, J., Assaad, H., Zoltowska, M., Michaud, S., Berger, D., Somero, M. S., Moyle, G. J., Brown, S., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181cbdaff · Cited by 79
Mercier, I., Jasmin, J.-F., Pavlides, S., Minetti, C., Flomenberg, N., Pestell, R. G., Frank, P. G., Sotgia, F., & Lisanti, M. P. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.23 · Cited by 77
Falutz, J., Allas, S., Kotler, D. P., Thompson, M., Koutkia, P., Albu, J., Trottier, B., Routy, J., Cote, P., Abribat, T., et al. (2005) · AIDS · doi:10.1097/01.aids.0000180099.35146.30 · Cited by 75
Hürlimann, D., Chenevard, R., Ruschitzka, F., Flepp, M., Enseleit, F., Béchir, M., Kobza, R., Muntwyler, J., Ledergerber, B., Lüscher, T. F., et al. (2005) · Heart · doi:10.1136/hrt.2004.056523 · Cited by 75
Sutinen, J., Walker, U. A., Sevastianova, K., Klinker, H., Häkkinen, A., Ristola, M. A., & Yki‐Järvinen, H. (2007) · Antiviral Therapy · doi:10.1177/135965350701200113 · Cited by 74
A randomized placebo‐controlled trial of metformin for the treatment of HIV lipodystrophy
Kohli, R., Shevitz, A., Gorbach, S., & Wanke, C. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00488.x · Cited by 74
Owen, K. R., Donohoe, M. E., Ellard, S., & Hattersley, A. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01034.x · Cited by 70
Monajemi, H., Zhang, L., Li, G., Jeninga, E. H., Cao, H., Maas, M. M., Brouwer, C. B., Kalkhoven, E., Stroes, E. S. G., Hegele, R. A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1807 · Cited by 70
Childhood acquired lipodystrophy: A retrospective study
Pope, E., Janson, A., Khambalia, A., & Feldman, B. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.005 · Cited by 69
Oral, E. A., Javor, E. D., Ding, L., Uzel, G., Cochran, E. K., Young, J. R., DePaoli, A. M., Holland, S. M., & Görden, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1220 · Cited by 69
Tan, K. M. L., KIMBER, W. A., Luan, J., Soos, M. A., Semple, R. K., Wareham, N. J., O’Rahilly, S., & Barroso, I. (2007) · Diabetes · doi:10.2337/db06-0921 · Cited by 68
Dubé, M. P., Komarow, L., Mulligan, K. M., Grinspoon, S. K., Parker, R. A., Robbins, G. K., Roubenoff, R., & Tebas, P. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181142d26 · Cited by 66
Bryant, A., Leighty, R. M., Shen, X., & Brouwers, P. Y. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3180691145 · Cited by 65
Nolan, D. A., Watts, G. F., Herrmann, S., French, M. A., John, M., & Mallal, S. A. (2003) · QJM · doi:10.1093/qjmed/hcg145 · Cited by 63
Niacin in HIV-Infected Individuals with Hyperlipidemia Receiving Potent Antiretroviral Therapy
Gerber, M. T., Mondy, K. E., Yarasheski, K. E., Drechsler, H., Claxton, S., Stoneman, J. S., DeMarco, D., Powderly, W. G., & Tebas, P. (2004) · Clinical Infectious Diseases · doi:10.1086/422144 · Cited by 63
Sevastianova, K., Sutinen, J., Kannisto, K., Hamsten, A., Ristola, M. A., & Yki‐Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90224.2008 · Cited by 62
Antuna-Puente, B., Boutet, E., Vigouroux, C., Lascols, O., Slama, L., Caron, M., Khallouf, E., Lévy‐Marchal, C., Capeau, J., Bastard, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1824 · Cited by 60
The role of diet, exercise and smoking in dyslipidaemia in HIV‐infected patients with lipodystrophy
Shah, M., Tierney, K., ADAMS-HUET, B. A., Boonyavarakul, A., Jacob, K. N., Quittner, C., Dinges, W., Peterson, D. M., & Garg, A. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00309.x · Cited by 60
Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients
Coll, B., Aragonès, G., Parra, S., Alonso‐Villaverde, C., & Masana, L. (2006) · AIDS · doi:10.1097/01.aids.0000238418.43937.3b · Cited by 59
McDermott, A. Y., Terrin, N. C., Wanke, C. A., Skinner, S. C., Tchetgen, E. J. T., & Shevitz, A. (2005) · Clinical Infectious Diseases · doi:10.1086/498022 · Cited by 58
Gambineri, A., Semple, R. K., Forlani, G., Genghini, S., Grassi, I., Hyden, C. S. S., Pagotto, U., O’Rahilly, S., & Pasquali, R. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0272 · Cited by 58
Beltrand, J., Lahlou, N., Charpentier, T. L., Sebag, G. H., Leka, S., Polak, M., Tubiana‐Rufi, N., Lacombe, D., de Kerdanet, M., Huet, F., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1027 · Cited by 58
Wong, S. L., DePaoli, A. M., Lee, J. H., & Mantzoros, C. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031931 · Cited by 57
Self-citationGavrila, A., Hsu, W., Tsiodras, S., Doweiko, J. P., Gautam, S., Martin, L., Moses, A. C., Karchmer, A. W., & Mantzoros, C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/427697 · Cited by 57
Self-citationGrünfeld, C., Thompson, M., Brown, S. J., Richmond, G. J., Lee, D. C., Muurahainen, N., & Kotler, D. P. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31804a7f68 · Cited by 57
High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition
Hendricks, K. M., Dong, K. R., Tang, A., Ding, B., Spiegelman, D. L., Woods, M. N., & WANKE, C. A. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.790 · Cited by 56
Meixner, L., Hoffman, J., Zwickl, B., Goldman, M. H., Whitely, K., Conrad, A., Fichtenbaum, C. J., Hyc, F., Spitz, T., Shaw, D. D., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100802 · Cited by 55
Domingo, P., Sambeat, M. A., Pérez, A., Ordóñez‐Llanos, J., Rodrı́guez-Espinosa, J., & Vázquez-Mata, G. (2003) · Antiviral Therapy · doi:10.1177/135965350300800306 · Cited by 54
Tsiodras, S., Poulia, K., Yannakoulia, M., Chimienti, S. N., Wadhwa, S. G., Karchmer, A. W., & Mantzoros, C. S. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.012 · Cited by 52
Self-citationMicroarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs
Pacenti, M., Barzon, L., Favaretto, F., et al. (2006) · AIDS · doi:10.1097/01.aids.0000242815.80462.5a · Cited by 52
The role of adipokines in relation to HIV lipodystrophy
Sweeney, L. L., Brennan, A., & Mantzoros, C. S. (2007) · AIDS · doi:10.1097/qad.0b013e3280adc91e · Cited by 50
Self-citationAdipose Tissue Integrity as a Prerequisite for Systemic Energy Balance
Anghel, S. I., Bedu, E., Delucinge-Vivier, C., Descombes, P., Desvergne, B., & Wahli, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702490200 · Cited by 49
Genetic analysis implicates resistin in HIV lipodystrophy
Ranade, K., Geese, W. J., Noor, M. A., Flint, O. P., Tebas, P., Mulligan, K. M., Powderly, W. G., Grinspoon, S. K., & Dubé, M. P. (2008) · AIDS · doi:10.1097/qad.0b013e32830a9886 · Cited by 49
Chan, J. L., Wong, S. L., & Mantzoros, C. S. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847110-00006 · Cited by 49
Self-citationSievers, M., Walker, U. A., Sevastianova, K., Setzer, B., Wågsäter, D., Eriksson, P. O., Yki-Järvinen, H., & Sutinen, J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599986 · Cited by 49
Simha, V., Agarwal, A. K., Aronin, P. A., Iannaccone, S. T., & Garg, A. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32457 · Cited by 48
Gavrila, A., Tsiodras, S., Doweiko, J. P., Nagy, G. S., Brodovicz, K. G., Hsu, W., Karchmer, A. W., & Mantzoros, C. S. (2003) · Clinical Infectious Diseases · doi:10.1086/375225 · Cited by 48
Self-citationFlorindo, A. A., Latorre, M. D. R. D. D. O., Jaime, P. C., & Segurado, A. A. C. (2007) · International Journal of STD & AIDS · doi:10.1258/095646207782193795 · Cited by 47
Leptin therapy for partial lipodystrophy linked to a PPAR‐γ mutation
Guettier, J., Park, J. Y., Cochran, E. K., Poitou, C., Basdevant, A., Meier, M., Clément, K., Magré, J., & Görden, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03095.x · Cited by 47
Magkos, F., & Mantzoros, C. S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.09.011 · Cited by 46
Self-citationMaagaard, A., & Kvale, D. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903186181 · Cited by 46
A Randomized, Placebo‐Controlled Trial of Rosiglitazone for HIV‐Related Lipoatrophy
Cavalcanti, R. B., Raboud, J., Shen, S., Kain, K. C., Cheung, A. M., & Walmsley, S. L. (2007) · The Journal of Infectious Diseases · doi:10.1086/518005 · Cited by 45
Divi, R. L., Haverkos, K. J., Humsi, J. A., Shockley, M. E., Thamire, C., Nagashima, K., Olivero, O. A., & Poirier, M. C. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20245 · Cited by 43
Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report
Moreau, F., Boullu-Sanchis, S., Vigouroux, C., Lucescu, C., Lascols, O., Sapin, R., Ruimy, D., Guerci, B., Pinget, M., & Jeandidier, N. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.04.005 · Cited by 43
Hadigan, C. M., Liebau, J., Torriani, M., Andersen, R., & Grinspoon, S. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1174 · Cited by 41
Approach to the Human Immunodeficiency Virus-Infected Patient with Lipodystrophy
Brown, T. T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1019 · Cited by 40
Macallan, D. C., Baldwin, C., Mandalia, S., Pandol-Kaljevic, V., Higgins, N., Grundy, A., & Moyle, G. J. (2008) · HIV Clinical Trials · doi:10.1310/hct0904-254 · Cited by 39
Gomes, K. B., Fernandes, A. P., Ferreira, A. C. S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030415 · Cited by 39
Martínez, E., Domingo, P., Ribera, E., Milinkovic, A., Arroyo, J. A., Conget, I., Pérez-Cuevas, J. B., Casamitjana, R., de Lazzari, E., Bianchi, L., et al. (2003) · Antiviral Therapy · doi:10.1177/135965350300800507 · Cited by 38
Lüdtke, A., Heck, K., Genschel, J., Mehnert, H., Spuler, S., Worman, H. J., & Schmidt, H. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01757.x · Cited by 38
Fenofibrate Is Effective in Treating Hypertriglyceridemia Associated with HIV Lipodystrophy
Rao, A., D’Amico, S., Balasubramanyam, A., & Maldonado, M. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200406000-00003 · Cited by 37
A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy
Raboud, J., Diong, C. C., Carr, A. D., Grinspoon, S. K., Mulligan, K. M., Sutinen, J., Rozenbaum, W., Cavalcanti, R. B., Wand, H. C., Costagliola, D. G., et al. (2010) · HIV Clinical Trials · doi:10.1310/hct1101-39 · Cited by 37
GH/GHRH axis in HIV lipodystrophy
Stanley, T. L., & Grinspoon, S. K. (2008) · Pituitary · doi:10.1007/s11102-008-0092-8 · Cited by 36
Shlay, J. C., Sharma, S., Peng, G., Gibert, C. L., & Grünfeld, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181aa1308 · Cited by 35
Comparison of Gemfibrozil and Fenofibrate in Patients with Dyslipidemic Coronary Heart Disease
Packard, K. A., Backes, J. M., Lenz, T. L., Wurdeman, R. L., Destache, C. J., & Hilleman, D. E. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.17.1527.34128 · Cited by 35
Chan, J. L., Wong, S. L., Orlova, C., Raciti, P. M., & Mantzoros, C. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2864 · Cited by 34
Self-citationBrennan, A. M., Lee, J. H., Tsiodras, S., Chan, J. L., Doweiko, J. P., Chimienti, S. N., Wadhwa, S. G., Karchmer, A. W., & Mantzoros, C. S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0597 · Cited by 34
Self-citationMuscle and nerve pathology in Dunnigan familial partial lipodystrophy
Spuler, S., Kalbhenn, T., Zabojszcza, J., van Landeghem, F. K. H., Lüdtke, A., Wenzel, K., Koehnlein, M. R., Schuelke, M., Lüdemann, L., & Schmidt, H. (2007) · Neurology · doi:10.1212/01.wnl.0000255939.73424.f8 · Cited by 34
Simha, V., Rao, S., & Garg, A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00978.x · Cited by 33
Wilson, D. E., Chan, I.-F., Stevenson, K., Horton, S. C., & SCHIPKE, C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-517 · Cited by 33
Leyes, P., Martínez, E., & Forga, M. (2008) · Antiviral Therapy · doi:10.1177/135965350801300208 · Cited by 29
Strategies for management and treatment of dyslipidemia in HIV/AIDS
Sax, P. E. (2005) · AIDS Care · doi:10.1080/09540120500161843 · Cited by 29
Are HIV positive patients resistant to statin therapy?
Johns, K., Bennett, M. T., & Bondy, G. P. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-27 · Cited by 29
Adiponectin: Novelties in Metabolism and Hormonal Regulation
Duntas, L. H., POPOVIC, V. M., & Panotopoulos, G. (2004) · Nutritional Neuroscience · doi:10.1080/10284150400009998 · Cited by 27
Lee, B., Aurpibul, L., D, V. S. M., Mangklabruks, A., Sirisanthana, T., & Puthanakit, T. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00653.x · Cited by 23
Mantzoros, C. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0340 · Cited by 22
Self-citationIwanishi, M., Ebihara, K., Kusakabe, T., Chen, W., Ito, J., Masuzaki, H., Hosoda, K., & Nakao, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.043 · Cited by 21
Leptin therapy in lipodystrophy
Savage, D. B., & O’Rahilly, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1545-y · Cited by 19
Luzi, L., Meneghini, E., Oggionni, S., Tambussi, G., Piceni-Sereni, L., & Lazzarin, A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02039 · Cited by 19
Feldt, T., Oette, M., Kroidl, A., Göbels, K., Fritzen, R., Kambergs, J., Kappert, G., Vogt, C., Wettstein, M., & Häussinger, D. (2006) · Infection · doi:10.1007/s15010-006-5022-y · Cited by 18
Bickel, M., Zangos, S., Jacobi, V., et al. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00399.x · Cited by 17
Hadigan, C. M., Mazza, S., Crum, D., & Grinspoon, S. K. (2007) · AIDS · doi:10.1097/qad.0b013e3282f25123 · Cited by 16
Turčinov, D., Stanley, C. M., Rutherford, G. W., Novotny, T. E., & Begovać, J. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9330-2 · Cited by 15
Oette, M., Kurowski, M., Feldt, T., Kroidl, A., Sagir, A., Vogt, C., Wettstein, M., & Häussinger, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki234 · Cited by 14
Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions
Kotler, D. P. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01951.x · Cited by 13
Schindler, K., Rieger, A., Tura, A., Gmeinhardt, B., Touzeau‐Römer, V., Haider, D. G., Pacini, G., & Ludvik, B. H. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1202779 · Cited by 13
W(h)ither Metreleptin for Lipodystrophy and the Metabolic Syndrome?
Mantzoros, C. S. (2010) · Endocrine Practice · doi:10.4158/ep10038.ed · Cited by 11
Self-citationDIEHL, L. A., Fabris, B. A., Barbosa, D. S., de Faria, E. C., Wiechmann, S. L., & Carrilho, A. J. F. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0012 · Cited by 10
Honda, M., Yogi, A., Ishizuka, N., Genka, I., Gatanaga, H., Teruya, K., Tachikawa, N., Kikuchi, Y., & Oka, S. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6122 · Cited by 7
Acquired partial lipodystrophy in an 11‐year‐old girl
Oświęcimska, J. M., Ziora, K. T., Geisler, G., & Dyduch, A. (2008) · Pediatrics International · doi:10.1111/j.1442-200x.2008.02713.x · Cited by 7
Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: A Randomized Trial
van Wijk, J. P. H., de Koning, E. J. P., Cabezas, M. C., op't Roodt, J., Joven, J., Rabelink, T. J., & Hoepelman, A. I. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00009 · Cited by 3
Cited by
Leptin in Human Physiology and Pathophysiology
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S.-Y., Hamnvik, O.-P. R., & Koniaris, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00315.2011 · Cited by 593
Self-citationThiazolidinediones and the promise of insulin sensitization in type 2 diabetes
Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518
Coats, B. R., Schoenfelt, K. Q., Barbosa-Lorenzi, V. C., Peris, E., Cui, C., Hoffman, A., Zhou, G., Fernandez, S., Zhai, L., Hall, B. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.096 · Cited by 291
The role of leptin in regulating bone metabolism
Upadhyay, J., Farr, O. M., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.021 · Cited by 268
Self-citationLeptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
Moon, H.-S., Dalamaga, M., Kim, S.-Y., Polyzos, S. A., Hamnvik, O.-P., Magkos, F., Paruthi, J., & Mantzoros, C. S. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1053 · Cited by 258
Self-citation
Metadata
- Authors
- Fiorenza, C. G., Chou, S. H., & Mantzoros, C. S.
- Venue
- Nature Reviews Endocrinology
- Published
- 2010-11-16
- Volume
- 7
- Issue
- 3
- Pages
- 137-150
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2020803051
- Cited by
- 255
- References
- 197
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.